Clinical Trials

RenovaCare, Inc., announced that its Investigational Device Exemption (IDE) application has been granted full approval by the U.S. Food and Drug Administration (FDA). This...

NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that...

Innocoll Biotherapeutics announced that it initiated two Phase 3 trials to support a label expansion for its collagen drug-device implant. Athlone, Ireland-based Innocoll’s trials are seeking...

International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4 non-small cell...

Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to...

Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial of eAUS in patients suffering from...

Pixium’s PRIMAvera study is an open-label, baseline-controlled, nonrandomized, multi-center, prospective, single-arm confirmatory trial of the Prima System. The implant is a bionic vision system...

Nevro touted results from a trial of its Senza system for treating painful diabetic neuropathy (PDN)-related chronic pain. Redwood City, Calif.-based Nevro, which published the...

The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer. Akili Interactive has published the full data from its STARS-ADHD Adjunctive trial....